SCHEMBL1672663

SCHEMBL1672663

O=CC(O)CCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8652035 1.00
SCHEMBL16600521 0.84 AKR1B1 (0.48)
SCHEMBL3433856 0.82
SCHEMBL8654801 0.82
SCHEMBL8654047 0.82
SCHEMBL5174808 0.80
SCHEMBL23839827 0.78 AKR1B1 (0.48)
SCHEMBL8016416 0.78 AKR1B1 (0.48)
SCHEMBL5175840 0.78 AKR1B1 (0.48)
SCHEMBL17105637 0.76 AKR1B1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025048724-A1 PRODUCTION OF METHIONINE VIA CONDENSATION OF C1-DERIVED FORMYL-COA WITH 3-HYDROXYPROPIONALDEHYDE DERIVED FROM VARIOUS SUBSTRATES MOJIA BIOTECH PTE. LTD. (SG) 2025-03-06 WO claimed
CN-118619917-A Preparation method of alpha-lipoic acid 苏州富士莱医药股份有限公司 2024-09-10 CN claimed
CN-114031750-A Low-temperature thin-coating type phenolic aldehyde amine curing agent and preparation method thereof 山东天茂新材料科技股份有限公司 2022-02-11 CN claimed
CN-107771214-B Modified microorganisms for optimized 2,4-dihydroxybutyric acid production with increased 2,4-dihydroxybutyric acid excrements 代谢探索者公司 2022-01-18 CN claimed
EP-3280694-B1 MODIFIED MICROORGANISM FOR THE OPTIMIZED PRODUCTION OF 2,4-DIHYDROXYBURYRATE METABOLIC EXPLORER SA (FR) 2021-11-24 EP claimed
US-10415062-B2 Modified microorganism for the optimized production of 2,4-dihydroxybutyrate METABOLIC EXPLORER (FR) 2019-09-17 US claimed
US-20180100169-A1 MODIFIED MICROORGANISM FOR THE OPTIMIZED PRODUCTION OF 2,4-DIHYDROXYBUTYRATE METABOLIC EXPLORER (FR) 2018-04-12 US claimed
EP-3280694-A1 MODIFIED MICROORGANISM FOR THE OPTIMIZED PRODUCTION OF 2,4-DIHYDROXYBURYRATE Metabolic Explorer (FR) 2018-02-14 EP claimed
CN-107690482-A The microorganism through modification for the optimization production of 2,4 dihydroxy butyric acid 代谢探索者公司 2018-02-13 CN claimed
WO-2016162712-A1 MODIFIED MICROORGANISM FOR THE OPTIMIZED PRODUCTION OF 2,4-DIHYDROXYBURYRATE METABOLIC EXPLORER (FR) 2016-10-13 WO claimed
CN-101333208-A Method for preparing 3,4,-O-isopropylidene-3,4-dihydroxy butyraldehyde SHANGHAI INST PHARM INDUSTRY (CN) 2008-12-31 CN claimed
US-20070248996-A1 Modulators of beta-amyloid peptide aggregation comprising D-amino acids PARAECIS PHARMACEUTICALS, INC. (US) 2007-10-25 US claimed
EP-1553128-B1 FOAMED INJECTION MOLDED ITEM AND METHOD OF FOAM INJECTION MOLDING POLYPLASTICS CO (JP) 2007-02-21 EP claimed
US-20060014696-A1 Modulators of beta-amyloid peptide aggregation comprising D-amino acids PRAECIS PHARMACEUTICALS, INC. (US) 2006-01-19 US claimed
EP-0929574-B1 MODULATORS OF beta-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS PRAECIS PHARM INC (US) 2005-06-29 EP claimed
US-20020103134-A1 Modulators of beta-amyloid peptide aggregation comprising D-amino acids PRAECIS PHARMACEUTICALS INC. 2002-08-01 US claimed
US-5985242-A PEPTIDE OF 3 TO 5 D-AMINO ACIDS; MAY BE MODIFIED AT AMINO-AND/OR CARBOXY TERMINUS; FOR TREATMENT OF AMYLOIDOSIS, ALZHEIMER'S DISEASE PRAECIS PHARMACEUTICALS, INC. (US) 1999-11-16 US claimed
EP-0929574-A1 MODULATORS OF beta-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS Praecis Pharmaceuticals Incorporated (US) 1999-07-21 EP claimed
WO-1998008868-A9 MODULATORS OF β-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS 1998-05-28 WO claimed
WO-1998008868-A1 MODULATORS OF β-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS PRAECIS PHARMACEUTICALS INCORPORATED (US) 1998-03-05 WO claimed